<doc>
  <docmeta id="113hr460ih">
    <bill congress="113" type="hr" number="460" version="ih"/>
    <revision size="5705" annotations="0" id="4" commit-time="2013-03-12T19:48:07+00:00" committer="favila" doc="113hr460ih/4.xml" status="complete">
      <description/>
    </revision>
  </docmeta>
  <bill bill-stage="Introduced-in-House" bill-type="olc" dms-id="H291C196D6A7F49F8BE4D1263F9176243" public-private="public">
	<form>
		<distribution-code display="yes">I</distribution-code>
		<congress>113th CONGRESS</congress>
		<session>1st Session</session>
		<legis-num>H. R. 460</legis-num>
		<current-chamber>IN THE HOUSE OF REPRESENTATIVES</current-chamber>
		<action>
			<action-date date="20130204">February 4, 2013</action-date>
			<action-desc>
        <sponsor name-id="M001180">Mr. McKinley</sponsor> (for
			 himself, <cosponsor name-id="C001036">Mrs. Capps</cosponsor>,
			 <cosponsor name-id="C001047">Mrs. Capito</cosponsor>,
			 <cosponsor name-id="Y000031">Mr. Young of Florida</cosponsor>,
			 <cosponsor name-id="M000933">Mr. Moran</cosponsor>,
			 <cosponsor name-id="W000672">Mr. Wolf</cosponsor>, <cosponsor name-id="T000469">Mr. Tonko</cosponsor>, <cosponsor name-id="R000594">Mr.
			 Runyan</cosponsor>, <cosponsor name-id="C000714">Mr. Conyers</cosponsor>,
			 <cosponsor name-id="B001278">Ms. Bonamici</cosponsor>,
			 <cosponsor name-id="C001084">Mr. Cicilline</cosponsor>,
			 <cosponsor name-id="D000191">Mr. DeFazio</cosponsor>,
			 <cosponsor name-id="M001149">Mr. Michaud</cosponsor>,
			 <cosponsor name-id="F000030">Mr. Farr</cosponsor>, <cosponsor name-id="P000597">Ms. Pingree of Maine</cosponsor>,
			 <cosponsor name-id="R000053">Mr. Rangel</cosponsor>, and
			 <cosponsor name-id="C001045">Mr. Crenshaw</cosponsor>) introduced the following
			 bill; which was referred to the <committee-name committee-id="HIF00">Committee
			 on Energy and Commerce</committee-name>
      </action-desc>
		</action>
		<legis-type>A BILL</legis-type>
		<official-title>To amend title XXVII of the Public Health Service Act to
		  limit co-payment, coinsurance, or other cost-sharing requirements applicable to
		  prescription drugs in a specialty drug tier to the dollar amount (or its
		  equivalent) of such requirements applicable to prescription drugs in a
		  non-preferred brand drug tier, and for other purposes.</official-title>
	</form>
	<legis-body id="H7FD80E8C9B2C4A23BCEEC56C550D0AFE" style="OLC">
		<section id="H0BF352CBC51343DFAF57AB52258BD5DC" section-type="section-one">
      <enum>1.</enum>
      <header>Short title</header>
      <text display-inline="no-display-inline">This Act may be cited as the
			 <quote>
          <short-title>Patients’ Access to Treatments Act of
			 2013</short-title>
        </quote>.</text>
		</section>
    <section id="H9B023CBC47494D5B9817A070E06C5272">
      <enum>2.</enum>
      <header>Cost-sharing
			 requirements applicable to prescription drugs in a specialty drug tier</header>
			<subsection id="HF20A42F24D3442AEB5E84D5D4AC4C5C5">
        <enum>(a)</enum>
        <header>In
			 general</header>
        <text display-inline="yes-display-inline">
          <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
            <cato:entity-ref entity-type="act" value="Public Health Service Act/t:XXVII/pt:A/spt:II">Subpart II of part A
			 of title XXVII of the Public Health Service Act</cato:entity-ref> (<cato:entity-ref entity-type="uscode" value="usc/42/300gg/etseq">42 U.S.C. 300gg et seq.</cato:entity-ref>)</cato:entity> is
			 amended by adding at the end the following:</text>
				<quoted-block display-inline="no-display-inline" id="HCB04BB30BAFC451897705A7C65280FBD" style="OLC">
					<section id="H44961867F4914BFD94FD2BBB06C3C530">
            <enum>2719B.</enum>
            <header>Cost-sharing
				requirements applicable to prescription drugs in a specialty drug tier</header>
						<subsection id="H5E191DE53A354E99876A7F1CB0BAD474">
              <enum>(a)</enum>
              <header>Requirement</header>
              <text>A
				group health plan, or a health insurance issuer offering group or individual
				health insurance, that provides coverage for prescription drugs and uses a
				formulary or other tiered cost-sharing structure shall not impose cost-sharing
				requirements applicable to prescription drugs in a specialty drug tier that
				exceed the dollar amount (or its equivalent) of cost-sharing requirements
				applicable to prescription drugs in a non-preferred brand drug tier (or
				prescription drugs in a brand drug tier if there is no non-preferred brand drug
				tier).</text>
						</subsection>
            <subsection id="H46C62FC406244BA8B3F6AA3560E7D218">
              <enum>(b)</enum>
              <header>Special
				rule</header>
              <text>If a formulary used by a group health plan or a health
				insurance issuer offering group or individual health insurance contains more
				than one non-preferred brand drug tier, then the requirements of <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:2719B/ss:a" proposed="true">subsection (a)</cato:entity-ref>
				shall be applied with respect to the non-preferred brand drug tier for which
				beneficiary cost-sharing is lowest.</text>
						</subsection>
            <subsection id="H4833924F8E2C46CBB09AFBF743C84A9A">
              <enum>(c)</enum>
              <header>Definitions</header>
              <text display-inline="yes-display-inline">In this section:</text>
							<paragraph id="HB3BDE2311F6F46BA9FC633487CFE01A5">
                <enum>(1)</enum>
                <text>The term
				<term>cost-sharing</term> includes co-payment and coinsurance.</text>
							</paragraph>
              <paragraph id="H12C027F4D5BF483BAAEB6B4788F2EF8D">
                <enum>(2)</enum>
                <text>The term
				<term>drug tier</term> means, with respect to a group health plan or health
				insurance issuer offering group or individual health insurance coverage that
				uses a formulary or other cost-sharing structure, a category of drugs—</text>
								<subparagraph id="HFE43488F535B482882487F1C4A286EC8">
                  <enum>(A)</enum>
                  <text>within such
				formulary or structure for which the total dollar amount of cost-sharing
				requirements for any drug does not vary by more than ten percent from the total
				dollar amount of cost-sharing requirements for any other drug; and</text>
								</subparagraph>
                <subparagraph id="H4EA7E806CF6B4C4CADC0DF7300944567">
                  <enum>(B)</enum>
                  <text>that are
				prescription drugs.</text>
								</subparagraph>
              </paragraph>
              <paragraph id="H0392C2B993414AF5B9B665A0CC0302E8">
                <enum>(3)</enum>
                <text>The term
				<term>non-preferred brand drug tier</term> means, with respect to a group
				health plan or health insurance issuer offering group or individual health
				insurance coverage that uses a formulary or other tiered cost-sharing
				structure, a category of drugs—</text>
								<subparagraph id="HCBA06120B2404162B2E4A54B83DD0A41">
                  <enum>(A)</enum>
                  <text display-inline="yes-display-inline">within a drug tier in such formulary or
				structure for which beneficiary cost-sharing is greater than drug tiers for
				generic drugs or preferred brand drugs in the formulary or structure;</text>
								</subparagraph>
                <subparagraph id="HD739C39DCE3A44D9A26305234E621A04">
                  <enum>(B)</enum>
                  <text>that are
				prescription drugs; and</text>
								</subparagraph>
                <subparagraph id="H941F4EC307B649ADA9F4ACB4CC8A70DC">
                  <enum>(C)</enum>
                  <text>that are not
				included within a specialty drug tier.</text>
								</subparagraph>
              </paragraph>
              <paragraph id="HA2D46E9B3370417BAC49EA48918A9005">
                <enum>(4)</enum>
                <text>The term
				<term>prescription drug</term> means—</text>
								<subparagraph id="HD6DB3E19AAF24BBDBE18D4A986BB1C87">
                  <enum>(A)</enum>
                  <text>a drug subject to
				<cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, or Cosmetic Act/s:503/ss:b/p:1">section 503(b)(1) of the Federal Food, Drug, or Cosmetic Act</cato:entity-ref>; and</text>
								</subparagraph>
                <subparagraph id="HEB582B2691734E96A7D31A24E27688C1">
                  <enum>(B)</enum>
                  <text>includes a drug
				described in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:2719B/ss:c/p:4/sp:A" proposed="true">subparagraph (A)</cato:entity-ref> that is a biological product (as defined in
				<cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:351/ss:i">section 351(i) of this Act</cato:entity-ref>).</text>
								</subparagraph>
              </paragraph>
              <paragraph id="H4AEBE430F51340BE82CD4D986760934A">
                <enum>(5)</enum>
                <text>The term
				<term>specialty drug tier</term> means, with respect to a group health plan or
				health insurance issuer offering group or individual health insurance coverage
				that uses a formulary or other tiered cost-sharing structure, a category of
				drugs—</text>
								<subparagraph id="H271A65C3272846A2B448E65BC18C3804">
                  <enum>(A)</enum>
                  <text display-inline="yes-display-inline">within a drug tier in such formulary or
				structure for which beneficiary cost-sharing is greater than drug tiers for
				generic drugs, preferred brand drugs, or non-preferred drugs in the plan’s
				formulary; and</text>
								</subparagraph>
                <subparagraph id="H43C12DF8F3B04EE9AC3DDC350C5221C8">
                  <enum>(B)</enum>
                  <text>that are
				prescription
				drugs.</text>
								</subparagraph>
              </paragraph>
            </subsection>
          </section>
          <after-quoted-block>.</after-quoted-block>
        </quoted-block>
			</subsection>
      <subsection id="HA1A831C9A11744249ECD2795B39E1232">
        <enum>(b)</enum>
        <header>Effective
			 date</header>
        <text>
          <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act/s:2719B">Section 2719B of the Public Health Service Act</cato:entity-ref>, as added by
			 <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Patients' Access to Treatments Act of 2013/s:2/ss:a" proposed="true">subsection (a)</cato:entity-ref>, applies to plan years beginning on or after the date of the
			 enactment of this Act.</text>
			</subsection>
    </section>
  </legis-body>
</bill>
</doc>